Skip to main content
. 2018 Sep 3;8:13125. doi: 10.1038/s41598-018-31433-2

Figure 4.

Figure 4

Eve expression in the developing embryo. Embryos expressing dCas9-VPR under the control of αTubulin-84b-GAL4 driver in the absence (left panels) and presence (right panels) of eve-sgRNA. (A) Primary antibody directed against Eve shows the canonical 7 striped band in a stage 6–7 embryo as well as (B) ectopic Eve protein throughout the embryo when eve-sgRNA is present. (C,D) DAPI staining of nuclei in stage 14–15 embryos. At stage 14–15 (E) wild-type expression pattern of Eve seen in anal pad and mesoderm/heart muscle and (F) ectopic expression of Eve is seen throughout the embryo when eve-sgRNA is present. (G,H) FLAG antibody indicates expression of N-terminal FLAG-tagged dCas9-VPR (Supplementary Fig. 1B) throughout the embryo. (I,J) FLAG, EVE composite micrographs. Scale bar: 100 µm. Anterior to left, posterior to right in all images.